BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 101 filers reported holding BICYCLE THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.53 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,259 | +13.6% | 3,348 | +44.3% | 0.00% | – |
| Q2 2023 | $59,204 | +162.6% | 2,320 | +118.9% | 0.00% | – |
| Q1 2023 | $22,546 | -40.7% | 1,060 | -19.1% | 0.00% | – |
| Q4 2022 | $38,000 | +15.2% | 1,310 | -7.1% | 0.00% | – |
| Q3 2022 | $33,000 | +106.2% | 1,410 | +48.4% | 0.00% | – |
| Q2 2022 | $16,000 | -90.9% | 950 | -76.5% | 0.00% | – |
| Q1 2022 | $176,000 | -33.3% | 4,039 | -6.8% | 0.00% | – |
| Q4 2021 | $264,000 | +25.7% | 4,334 | -14.4% | 0.00% | – |
| Q3 2021 | $210,000 | -62.0% | 5,064 | -72.2% | 0.00% | -100.0% |
| Q2 2021 | $552,000 | +18.2% | 18,196 | +16.4% | 0.00% | 0.0% |
| Q1 2021 | $467,000 | +17.6% | 15,627 | -29.3% | 0.00% | 0.0% |
| Q4 2020 | $397,000 | -20.1% | 22,112 | -15.3% | 0.00% | 0.0% |
| Q3 2020 | $497,000 | -7.4% | 26,100 | -23.5% | 0.00% | -50.0% |
| Q2 2020 | $537,000 | +53600.0% | 34,100 | +34000.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 3,642,307 | $73,173,948 | 4.96% |
| Sio Capital Management, LLC | 796,933 | $16,010,384 | 4.96% |
| First Light Asset Management, LLC | 2,070,853 | $41,603,437 | 3.95% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,281,820 | $25,751,764 | 3.60% |
| Deep Track Capital, LP | 3,490,506 | $70,124,266 | 2.71% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,010,976 | $20,310,508 | 1.10% |
| HighVista Strategies LLC | 92,434 | $1,856,999 | 0.86% |
| BRAIDWELL LP | 1,289,872 | $25,913,528 | 0.82% |
| DAFNA Capital Management LLC | 122,200 | $2,454,998 | 0.76% |
| Soleus Capital Management, L.P. | 391,800 | $7,871,262 | 0.73% |